secwatch.observer — SEC 8-K summary
======================================

Issuer:     CASTLE BIOSCIENCES INC (CSTL)
CIK:        0001447362
Form:       8-K
Filed at:   2021-07-16T23:59:59+00:00
Accession:  0001447362-21-000166
Event type: leadership
Sentiment:  neutral
Materiality: 0.20
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Castle Biosciences appoints Kimberlee Caple and Ellen Goldberg to board
-----------------------------------------------------------------------

- Appointed Kimberlee Caple as Class III director (term until 2022 annual meeting).
- Appointed Ellen Goldberg as Class I director (term until 2023 annual meeting).
- Each receives $40,000 annual cash, 5,365 stock options, and 1,320 RSUs per standard policy.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1447362/000144736221000166/0001447362-21-000166-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1447362/000144736221000166/cstl-20210714.htm
  HTML page:      https://secwatch.observer/filing/0001447362-21-000166

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer